GlassScriptPhysician profile
Justin L Shields
NPI 1730471368
$639.04
in general payments reported to CMS, 2019-2025
13 companies · $15.25 in 2025
The $15.25 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $262 · 2022: $96.21 · 2023: $102 · 2024: $163 · 2025: $15.25.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $280.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $280.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $143.66 | 2021-2024 | Eliquis |
| Janssen Pharmaceuticals, INC | $129.10 | 2021-2022 | |
| Abbvie INC. | $64.25 | 2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $58.21 | 2022-2025 | Jardiance |
| Irhythm Technologies, INC. | $54.90 | 2023 | Zio Xt Patch |
| Mylan Specialty L.P. | $52.59 | 2021-2024 | Yupelri |
| Merck Sharp & Dohme LLC | $29.82 | 2024 | Recarbrio, Dificid, Zerbaxa |
| Boston Scientific Corporation | $27.32 | 2021 | |
| Alexion Pharmaceuticals, INC. | $18.00 | 2021 | |
| Pfizer INC. | $16.79 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $16.37 | 2021 | |
| Novo Nordisk INC | $14.67 | 2021 | |
| Gilead Sciences, INC. | $13.36 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Justin Shields listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.